dm+d
90356005
Medicine Compliance Aid Stability
Salagen
Merus Labs Luxco II S.à R.L.
Merus Labs Luxco II S.à R.L.
Salagen
Tablets f/c 5mg
R2 · Red 2 Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Unsuitable.
22 November 2022
Lactation Safety Information
For glaucoma
For glaucoma
Other antiglaucoma drug if appropriate
No published evidence of safety
Monitor infant for cholinergic effects (diarrhea, lacrimation, and excessive salivation or urination), although risk is theoretical and low
5 August 2020
For dry mouth
For dry mouth
No published evidence of safety
Monitor infant for signs of cholinergic side effects (diarrhoea, excessive salivation, sweating etc)
5 August 2020